Tech Company Financing Transactions
Isovalent Funding Round
On 9/7/2022, Isovalent secured $40 million in Series B funding from Thomvest Ventures, Andreessen Horowitz and Cisco Investments.
Transaction Overview
Company Name
Announced On
9/7/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Thomvest Ventures (Lead Investor) (Umesh Padval)
Proceeds Purpose
Isovalent will use the proceeds from the Series B fundraise to remain the leading force behind the eBPF community, and continue the rise of Cilium as the leading technology for Kubernetes networking, security, and service mesh.
Company Information
Company Status
Private & Independent
Industry
Security
Mailing Address
444 Castro St. 730
Mountain View, CA 94041
USA
Mountain View, CA 94041
USA
Phone
Undisclosed
Website
Email Address
Overview
Isovalent is the company building eBPF, Cilium, and re-inventing networking & security for the age of microservices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Wendlandt
Chief Technical Officer
Thomas Graf
Vice President
Neela Jacques
VP - Engineering
Beatriz Martínez
Browse more venture capital transactions:
Prev: 9/7/2022: 21.co venture capital transaction
Next: 9/7/2022: Trek Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs